Z Chen
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Biochemistry top 1%
- Antioxidant Activity and Oxidative Stress
Papers in
- Hematology 12
- Acute Myeloid Leukemia Research 12
- Chronic Myeloid Leukemia Treatments 1
-
- Antioxidant Activity and Oxidative Stress 4
- Co-authors
- G-Q Chen (7 shared papers)Wannan Tang (2 shared papers)XS Li (4 shared papers)Shyh‐Jye Chen (4 shared papers)Claude Gazin (2 shared papers)Takashi Naoe (2 shared papers)ZY Wang (2 shared papers)Jing Zhu (2 shared papers)
- Journals
- Leukemia (9 papers)Blood (3 papers)JNCI Journal of the National Cancer Institute (2 papers)Biomedicine & Pharmacotherapy (1 paper)PubMed (3 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Z Chen
18 papers receiving 2.0k citations
Z Chen's Hit Papers
Peers
Comparison fields: 5 of 84
- Hematology 924
- Biochemistry 352
- Molecular Biology 1.8k
- Environmental Chemistry 206
- Cancer Research 213
Countries citing papers authored by Z Chen
This map shows the geographic impact of Z Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z Chen more than expected).
Fields of papers citing papers by Z Chen
This network shows the impact of papers produced by Z Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z Chen. The network helps show where Z Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Z Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins Hit paper breakdown → | 1996 | 765 |
| 2 | 1999 | 257 | |
| 3 | 2000 | 234 | |
| 4 | 2001 | 131 | |
| 5 | 2003 | 93 | |
| 6 | 2012 | 79 | |
| 7 | 2005 | 77 | |
| 8 | Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia. | 1996 | 67 |
| 9 | 2009 | 65 | |
| 10 | 2003 | 65 | |
| 11 | 2001 | 61 | |
| 12 | 1999 | 60 | |
| 13 | 1996 | 55 | |
| 14 | The retinoic acid alpha receptor gene is frequently disrupted in its 5' part in Chinese patients with acute promyelocytic leukemia. | 1991 | 38 |
| 15 | 1996 | 29 | |
| 16 | Monoallelic deletions of the P53 gene in Chinese patients with chronic myelogenous leukemia in blastic crisis. | 1991 | 8 |
| 17 | 1992 | 1 | |
| 18 | 1999 | 1 |
About Z Chen
Z Chen is a scholar working on Hematology, Biochemistry, Molecular Biology, Ophthalmology and Cancer Research, having authored 18 papers that have together received 2.1k indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (15 papers), Acute Myeloid Leukemia Research (12 papers), Antioxidant Activity and Oxidative Stress (4 papers), Estrogen and related hormone effects (3 papers), Drug-Induced Ocular Toxicity (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Chronic Myeloid Leukemia Treatments (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Hematology (924 citations), Biochemistry (352 citations), Molecular Biology (1.8k citations), Environmental Chemistry (206 citations) and Cancer Research (213 citations). Z Chen has collaborated with scholars based in China, United States and France. Frequent co-authors include G-Q Chen, Wannan Tang, XS Li, Shyh‐Jye Chen, Claude Gazin, Takashi Naoe, ZY Wang, Jing Zhu, Jingqin Ma and Ying Huang. Their work appears in journals such as Leukemia, Blood, JNCI Journal of the National Cancer Institute, Biomedicine & Pharmacotherapy and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.